Results of CRS and Debulking in PMP Patients
Sponsor
Uppsala University (Other)
Overall Status
Unknown status
CT.gov ID
NCT01427101
Collaborator
(none)
Study Details
Study Description
Brief Summary
The aim of this study was to compare debulking surgery and cytoreductive surgery in patients with Pseudomyxoma Peritonei with respect to efficacy and safety.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Comparison Between Cyotreductive Surgery and Debulking Surgery in Patients With Pseudomyxoma Peritonei
Study Start Date
:
Sep 1, 1993
Outcome Measures
Primary Outcome Measures
- Overall survival []
from treatment and forward
Secondary Outcome Measures
- morbidity and mortality [90 days]
mortality is messured during the first 90 postoperative days and morbidity during hospital stay.
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Patients with radiology histopathology finding of Pseudomyxoma Peritonei
Exclusion Criteria:
- Preformance status WHO >2 and histopathology shows other origin then Pseudomyxoma Peritonei
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Uppsala University
Investigators
- Principal Investigator: Haile Mahteme, MD, PhD, Uppsala University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Uppsala University
ClinicalTrials.gov Identifier:
NCT01427101
Other Study ID Numbers:
- 2007/073-PMP-Andréasson
First Posted:
Sep 1, 2011
Last Update Posted:
Sep 1, 2011
Last Verified:
Aug 1, 2011
Keywords provided by Uppsala University
Additional relevant MeSH terms: